GENETIC TECHNOLOGIES LIMITED — Capital/Financing Update 2023

Feb 6, 2023

==> picture [95 x 61] intentionally omitted <==

7 February 2023

Company Announcements Office ASX Limited

Dear Sir/Madam

Genetic Technologies Limited

Cleansing Notice under section 708A of the Corporations Act 2001 (Cth)

On 6 February 2023 Genetic Technologies Limited ACN 009 212 328 (ASX: GTG; NASDAQ: GENE) (the Company ) announced that it had received commitments for an aggregate of US$5,000,002 (before expenses and costs of the issue) via a private placement of 2,307,693,000 fully paid ordinary shares ( Shares ) in the Company (represented by 3,846,155 American depositary shares ( ADS s) of the Company) to various US sophisticated and institutional investors introduced by HCW Wainwright & Co at an issue price of US$1.30 per ADS or the equivalent of A$0.003 per Share ( Placement ).

The Company gives this cleansing notice ( Notice ) under section 708A(5)(e) of the Corporations Act 2001 (Cth) ( Corporations Act ). The Placement Shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act.

As at the date of this Notice, the Company has complied with:

• the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

• section 674 of the Corporations Act.

As at the date of this Notice, there is no excluded information for the purposes of section 708A(7) and section 708A(8) of the Corporations Act.

Yours faithfully

==> picture [42 x 46] intentionally omitted <==

Mr Tony Di Pietro CFO and Company Secretary Genetic Technologies Limited

Genetic Technologies Limited 60-66 Hanover Street www.genetype.com Fitzroy Victoria 3065 info@gtglabs.com Australia ABN 17 009 212 328 +61 3 8412 7000